Home DNA test results from 23andMe to help develop drugs

July 26, 2018 Posted By: Leave a comment
TwitterFacebook

Pharmaceutical giant GlaxoSmithKline has invested $300 million into home DNA testing company 23andMe, allowing it to develop drugs based on human genetics.

The four-year agreement allows GSK access to 23andMe's vast database to accelerate its drug research and development work. 

SEE ALSO: The first...

Subscribe to Applenews247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>